Patents by Inventor Binqiang FENG

Binqiang FENG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230219951
    Abstract: A pyridine-pyrimidine derivative, a preparation method therefor and a pharmaceutical use thereof. In particular, the present disclosure relates to pyridine-pyrimidine derivative as shown in general formula (I), a preparation method therefor, a pharmaceutical composition containing the derivative, and a use thereof as a therapeutic agent, especially a use thereof as an SOS1 inhibitor and a use thereof in preparation of drugs for treating diseases, conditions or disorders improved by inhibiting SOS1.
    Type: Application
    Filed: June 11, 2021
    Publication date: July 13, 2023
    Inventors: Xin LI, Binqiang FENG, Dongdong BAI, Feng HE, Weikang TAO
  • Patent number: 10442793
    Abstract: The present invention relates to an oxa spiro derivative, a preparation method therefor, and applications thereof in medicines. Particularly, the present invention relates to an oxa spiro derivative represented by formula (I), a preparation method therefor, and a pharmaceutical composition comprising the derivative, applications thereof as an MOR receptor agonist, and applications in the preparation of drugs for treating and/or preventing pains and pains-related diseases. Substituent groups in the formula (I) are same as definitions in the specification.
    Type: Grant
    Filed: September 30, 2016
    Date of Patent: October 15, 2019
    Assignees: Jiangsu Hengrui Medicine Co., Ltd, Shanghai Hengrui Pharmaceutical Co., Ltd.
    Inventors: Xin Li, Binqiang Feng, Yang Chen, Tao Liu, Feng He, Mingxun He, Weikang Tao, Piaoyang Sun
  • Publication number: 20180297988
    Abstract: The present invention relates to an oxa spiro derivative, a preparation method therefor, and applications thereof in medicines. Particularly, the present invention relates to an oxa spiro derivative represented by formula (I), a preparation method therefor, and a pharmaceutical composition comprising the derivative, applications thereof as an MOR receptor agonist, and applications in the preparation of drugs for treating and/or preventing pains and pains-related diseases. Substituent groups in the formula (I) are same as definitions in the specification.
    Type: Application
    Filed: September 30, 2016
    Publication date: October 18, 2018
    Inventors: Xin LI, Binqiang FENG, Yang CHEN, Tao LIU, Feng HE, Mingxun HE, Weikang TAO, Piaoyang SUN